RE: Game Changer for Cannabinoids Process3 Mar 2021 01:00
some derampers posting Nonsense like is CBX worth it's valuation?
let's say Lancome, Lloreal Paris, Rimmel London etc where to Bring out a biosynthetic Cannabinoids cosmetics range, it would cost £100M+ on R&D, research and development.
CBX have done most of the Research and development under £100M, Cbx can't be valued less than that.
take Pharmaceutical industry, smaller companies do all the hard work as in R&D then bigger companies buy them out
there's always a value for every progress
GLA and Dyor